BUZZ-特朗普发出监管支持信号后，迷幻药开发商崛起

路透中文

Apr 20

BUZZ-特朗普发出监管支持信号后，迷幻药开发商崛起

4月20日 - ** 美国总统特朗普（Donald Trump）周六签署了一项行政命令 (link)，要求卫生监管机构加快对伊博格堿等迷幻药的审查，并拨出5000万美元用于研究，此后迷幻药开发商的股价在盘前上涨。

** Atai ATAI.O股价跳涨21%，Definium Therapeutics DFTX.O上涨18%，Compass Pathways CMPS.O攀升24%，GH Research GHRS.O上涨19%，Enveric ENVB.O在盘前上涨7%。

** 在美国上市的 Cybin HELP.O 股价上涨 15%

** 经纪公司杰富瑞（Jefferies）称，该命令是 "对该类产品的官方认可"，表明政府的支持是 "真实/可操作的(，而不是空谈)"

** 伊博格堿是从一种非洲灌木中提取的天然精神活性化合物，目前正被研究用于治疗成瘾和精神疾病。

** 杰富瑞指出，获得 "突破性疗法 "称号的迷幻药可能会获得 "局长国家优先审查券"，从而将食品及药物管理局的审查时间从 6-10 个月缩短到 1-2 个月。

(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2628454697"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2628454697\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2628454697?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-04-20 17:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2628454697","market":"hk","top_or_hot":-1,"title":"BUZZ-特朗普发出监管支持信号后，迷幻药开发商崛起","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-特朗普发出监管支持信号后，迷幻药开发商崛起</title></head><body><p>\n<span>4月20日</span><span> - </span>** 美国总统特朗普（Donald Trump）周六签署了一项行政命令 (<span>link</span>)，要求卫生监管机构加快对伊博格堿等迷幻药的审查，并拨出5000万美元用于研究，此后迷幻药开发商的股价在盘前上涨。</p><p>** Atai <span>ATAI.O</span>股价跳涨21%，<a href=\"https://laohu8.com/S/DFTX\">Definium Therapeutics</a> <span>DFTX.O</span>上涨18%，Compass Pathways <span>CMPS.O</span>攀升24%，GH Research <span>GHRS.O</span>上涨19%，Enveric <span>ENVB.O</span>在盘前上涨7%。</p><p>** 在美国上市的 Cybin <span>HELP.O</span> 股价上涨 15% </p><p>** 经纪公司<a href=\"https://laohu8.com/S/JEF\">杰富瑞</a>（Jefferies）称，该命令是 \"对该类产品的官方认可\"，表明政府的支持是 \"真实/可操作的(，而不是空谈)\"</p><p>** 伊博格堿是从一种非洲灌木中提取的天然精神活性化合物，目前正被研究用于治疗成瘾和精神疾病。</p><p>** 杰富瑞指出，获得 \"突破性疗法 \"称号的迷幻药可能会获得 \"局长国家优先审查券\"，从而将食品及药物管理局的审查时间从 6-10 个月缩短到 1-2 个月。</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-特朗普发出监管支持信号后，迷幻药开发商崛起</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-特朗普发出监管支持信号后，迷幻药开发商崛起\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time\">2026-04-20 17:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-特朗普发出监管支持信号后，迷幻药开发商崛起</title></head><body><p>\n<span>4月20日</span><span> - </span>** 美国总统特朗普（Donald Trump）周六签署了一项行政命令 (<span>link</span>)，要求卫生监管机构加快对伊博格堿等迷幻药的审查，并拨出5000万美元用于研究，此后迷幻药开发商的股价在盘前上涨。</p><p>** Atai <span>ATAI.O</span>股价跳涨21%，<a href=\"https://laohu8.com/S/DFTX\">Definium Therapeutics</a> <span>DFTX.O</span>上涨18%，Compass Pathways <span>CMPS.O</span>攀升24%，GH Research <span>GHRS.O</span>上涨19%，Enveric <span>ENVB.O</span>在盘前上涨7%。</p><p>** 在美国上市的 Cybin <span>HELP.O</span> 股价上涨 15% </p><p>** 经纪公司<a href=\"https://laohu8.com/S/JEF\">杰富瑞</a>（Jefferies）称，该命令是 \"对该类产品的官方认可\"，表明政府的支持是 \"真实/可操作的(，而不是空谈)\"</p><p>** 伊博格堿是从一种非洲灌木中提取的天然精神活性化合物，目前正被研究用于治疗成瘾和精神疾病。</p><p>** 杰富瑞指出，获得 \"突破性疗法 \"称号的迷幻药可能会获得 \"局长国家优先审查券\"，从而将食品及药物管理局的审查时间从 6-10 个月缩短到 1-2 个月。</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DFTX","symbol_name":"Definium Therapeutics","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nL4T4130IH:1","article_id":"2628454697","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2628454697","pubTimestamp":1776676608,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"4月20日 - ** 美国总统特朗普周六签署了一项行政命令 ，要求卫生监管机构加快对伊博格堿等迷幻药的审查，并拨出5000万美元用于研究，此后迷幻药开发商的股价在盘前上涨。** 杰富瑞指出，获得 \"突破性疗法 \"称号的迷幻药可能会获得 \"局长国家优先审查券\"，从而将食品及药物管理局的审查时间从 6-10 个月缩短到 1-2 个月。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"DFTX":"Definium Therapeutics","BK4007":"制药","ENVB":"Enveric Biosciences","CMPS":"COMPASS Pathways plc","BK4539":"次新股","ATAI":"Atai Beckley Inc","BK4139":"生物科技","GHRS":"GH Research PLC"},"translate_title":"BUZZ-LSD developers rise after Trump signals regulatory support","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ATAI":0.9,"DFTX":0.9,"ENVB":0.9,"GHRS":0.9,"CMPS":0.9},"content_text":"BUZZ-特朗普发出监管支持信号后，迷幻药开发商崛起\n4月20日 - ** 美国总统特朗普（Donald Trump）周六签署了一项行政命令 (link)，要求卫生监管机构加快对伊博格堿等迷幻药的审查，并拨出5000万美元用于研究，此后迷幻药开发商的股价在盘前上涨。** Atai ATAI.O股价跳涨21%，Definium Therapeutics DFTX.O上涨18%，Compass Pathways CMPS.O攀升24%，GH Research GHRS.O上涨19%，Enveric ENVB.O在盘前上涨7%。** 在美国上市的 Cybin HELP.O 股价上涨 15% ** 经纪公司杰富瑞（Jefferies）称，该命令是 \"对该类产品的官方认可\"，表明政府的支持是 \"真实/可操作的(，而不是空谈)\"** 伊博格堿是从一种非洲灌木中提取的天然精神活性化合物，目前正被研究用于治疗成瘾和精神疾病。** 杰富瑞指出，获得 \"突破性疗法 \"称号的迷幻药可能会获得 \"局长国家优先审查券\"，从而将食品及药物管理局的审查时间从 6-10 个月缩短到 1-2 个月。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}